GSK : Analysis & Opinions

  1. Diamond Hill's Highest Performing Mutual Fund Since Inception ...

    May 25, 2016
    Find out about Diamond Hill Capital Management's best-performing fund, the Research Opportunities Fund, and learn how it ...
  2. The Impact of Novartis' New Business Model (NVS)

    May 23, 2016
    Amid the exit of its U.S. business head, Novartis is splitting its pharma business. Here's a look at what this split means ...
  3. Legal Risk Study: XLV, How Much Fines Have Component Companies ...

    May 8, 2016
    Learn the reasons behind the fines paid by the top three pharmaceutical companies held by XLV, and why they might not prevent ...
  4. J&J Loses Second Talcum Powder Cancer Case

    May 4, 2016
    A jury recently ordered Johnson & Johnson to pay $55 million in damages to a woman who claimed that its talcum powder ...
  5. Global Health Care Technology: 5 Key Industry Players (JNJ, GSK)

    April 27, 2016
    Discover how to analyze which of these top five key global health care technology industry players best suit your portfolio ...
  6. The Market In 5 Minutes: Tuesday, April 5, 2016

    April 5, 2016
    Below is a tool used by the Benzinga News Desk each trading day -- it's a look at everything happening in the market, in ...
  7. FPHAX: Fidelity Select Pharma Fund Top 5 Holdings Analysis

    April 2, 2016
    Explore the five largest holdings of the Fidelity Pharmaceuticals Select Portfolio. Learn about the top products and drug ...
  8. FPHAX: Overview of Fidelity Select Pharmaceuticals Fund

    March 20, 2016
    Learn about the pharmaceutical industry, including the two main threats it faces in 2016 and an analysis of the Fidelity ...
  9. The Federated Strategic Value Dividend Fund: A Dividend Case ...

    March 11, 2016
    Learn about the head of the Federated Strategic Value Dividend Fund, Daniel Peris, and his dividend-oriented investment strategy.
  10. Is Big Pharma Under Pressure in 2016? (JNJ, GSK)

    March 8, 2016
    Find out why large pharmaceutical companies are coming under pressure by investors to break themselves up into smaller companies.
  11. How Novartis Probably Has a Cure for What Ails You

    January 21, 2016
    A look at the unparalleled growth of the world's biggest pharmaceutical company: Novartis AG.
  12. Why Biotech Affimed N.V. Should Be On Your Radar (JUNO, AFMD)

    December 8, 2015
    In the world of developmental biotech, picking the correct early stage companies can potentially make investors a fortune.
  13. Defensive Investing: Learn from a Hedge Fund Pro

    November 12, 2015
    Looking for ideas on companies, sectors or investments to short? Consider the opinion of this hedge fund luminary.
  14. The 5 Best Dividend Stocks in the Healthcare Sector (GSK, ABBV)

    October 7, 2015
    Learn about the top five dividend stocks of companies operating in the health care sector that generate substantial cash ...
  15. Glaxo in $1 Billion Ofatumumab Deal With Novartis (GSK, NVS)

    August 26, 2015
    In the latest deal between two pharmaceutical majors that clearly like doing business with each other, GlaxoSmithKline (NYSE: ...
  16. Make Room for Exelixis in Your Portfolio

    August 12, 2015
    Discover information and analysis on the biopharmaceutical company, Exelixis, and learn what makes it a good stock to consider ...
  17. Would Pfizer Buying GlaxoSmithKline Make Sense? (GSK, PFE)

    May 22, 2015
    Over the past five years, Pfizer (NYSE: PFE) and its shareholders have witnessed its stock price ascend by approximately ...
  18. Who are Gilead Sciences' (GILD) main competitors?

    May 22, 2015
    Learn about the pharmaceutical company Gilead Sciences and its main competitors. Explore the company's role in creating HIV-preventing ...
  19. 3 Top Pharma Stocks that Pay Regular Dividends (GSK, AZN)

    May 1, 2015
    The low down on three big name, dividend-paying pharma stocks.
  20. How the UK Makes Money

    April 29, 2015
    The United Kingdom has one of the strongest economies in the world thanks to the strength of its services, manufacturing ...
  21. How China Makes Money (PFE, GSK)

    April 28, 2015
    China has the first or second largest GDP in the world but is not nearly as developed as others in the top 10.
  22. The Future of Big Pharma Stocks

    March 31, 2015
    A look at the future health of big pharma stocks.
  23. Interested In Pharmaceutical Stocks? Try Novartis (ADR)

    February 26, 2015
    Novartis AG, is the world's leading pharmaceutical company by sales. Here is a closer look at Novartis, and how its financials ...
  24. The Best- and Worst-Performing Healthcare Stocks

    November 3, 2014
    Here are the best- and worst-performing stocks YTD in the healthcare sector with at least $2B in market cap and over 1 million ...
  25. Why There's Far More To Pfizer Than Viagra

    July 30, 2014
    Pfizer, Inc. is one of the world's largest and most profitable pharmaceutical companies, and not just because of that little ...
  26. European Stocks Are Ripe For The Picking

    February 26, 2014
    Things continue to get better for Europe. After going through some pretty nasty side-effects in the aftermath of the Great ...
  27. The United Kingdom Is Ripe For Stock Pickers

    December 6, 2013
    With the situation in Europe finally moving ahead, investors may want to focus on the United Kingdom. Stocks within the nation ...
  28. Big Pharma Faces 'Pay For Delay' Lawsuits

    June 21, 2013
    Unless you follow the pharmaceutical and biotech sectors, it’s likely that you’ve never heard of pay to delay. Instead of ...
  29. 10 Drug Stocks for Safety and Yields

    June 26, 2011
    Big pharma is an attractive destination for traders and investors looking for safety, yields, and solid value in the current ...
  30. The 5 Most Important Drugs In America

    July 28, 2009
    A look at the top-selling drugs finds that a few that make more of a difference to the company's bottom line than others.
Trading Center